Epicardial Automatic Implantable Cardiac Defibrillator In A Child With Symptomatic Bugada Syndrome
نویسندگان
چکیده
An 18 month old 14 kg male with symptomatic Brugada syndrome underwent placement of an epicardial automatic implantable cardiac defibrillator using a single coil transvenous lead sutured to the anterolateral aspect of the left ventricle.
منابع مشابه
Management of patients with long QT syndrome
I have read with great interest the case report entitled “Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome” by Sugiyama et al. in the latest issue of the journal [1]. The authors well presented a case of long QT syndrome managed using implantation of an epicardial shock electrode and dose titration of beta-blocker therapy. However, some imp...
متن کاملClinical aspects and prognosis of Brugada syndrome in children.
BACKGROUND Brugada syndrome is an arrhythmogenic disease characterized by an ECG pattern of ST-segment elevation in the right precordial leads and augmented risk of sudden cardiac death. Little is known about the clinical presentation and prognosis of this disease in children. METHODS AND RESULTS Thirty children affected by Brugada syndrome who were <16 years of age (mean, 8+/-4 years) were i...
متن کاملEpicardial mapping and ablation of the right ventricle substrate during flecainide testing in Brugada syndrome
Brugada syndrome (BrS) is characterized by ST-segment elevation in right precordial leads on 12-lead electrocardiogram (ECG) with associated sudden cardiac death because of ventricular fibrillation (VF). The ECGmanifestations of this syndrome are often dynamic or concealed and may be unmasked or modulated by sodium channel blockers, febrile state, vagotonic agents, α-adrenergic agonists, β-adre...
متن کاملMassive thrombi on an implantable cardioverter-defibrillator lead in a patient with the antiphospholipid syndrome.
A patient with the antiphospholipid syndrome, who was suboptimally anticoagulated, presented with two large thrombi attached to her implantable cardioverter-defibrillator lead. Anticoagulation was unsuccessful so, in view of the risk from embolization, the system was removed surgically and an epicardial system implanted to reduce the risk of future device-related thrombosis.
متن کاملAblation of the epicardial substrate in the right ventricular outflow tract in a patient with Brugada syndrome refusing implantable cardioverter defibrillator therapy.
Brugada syndrome is associated with a high risk of sudden cardiac death. Currently, the cornerstone of therapy is implantation of an implantable cardioverter defibrillator (ICD). Recently, a novel approach to preventively ablate the substrate located in the anterior epicardial region of the right ventricular outflow tract showed promising results by reducing the number of ventricular fibrillati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 11 شماره
صفحات -
تاریخ انتشار 2011